Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion type Assertion NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_head.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion wasGeneratedBy ECO_0000203 NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_provenance.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion wasDerivedFrom befree-2016 NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_provenance.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion SIO_000772 24837431 NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_provenance.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion evidence source_evidence_literature NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_provenance.
- NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_assertion description "[These results indicate that deregulation of EPHB4/RASA1/mTORC1 signaling in endothelial cells promotes vascular malformation and suggest that mTORC1 inhibitors, many of which are approved for the treatment of certain cancers, should be further explored as a potential strategy to treat patients with vascular malformations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1183266.RAijqm6PlElUcly803WxiDtsx36Dr0j4KyVvmrWxBIeBs130_provenance.